|
|
|
|
|
|
|
|
abstract
The Problem
Clinicians
may be unaware that industry payments to physicians are now publicly
searchable under the Physician Payments Sunshine Act. Furthermore, the
extent of industry’s financial involvement in subspecialty practice has
not been previously accessible. As an example, 6948 direct,
research-unrelated payments totaling $1,957,004 were made to 765
gynecologic oncologists in 2014, the first full year of data available. A
total of 153 companies reported at least 1 payment; however, the 10
manufacturers reporting the highest total payment amount accounted for
82% of all payments to physicians. In all, 48 gynecologic oncologists
received >$10,000 from manufacturers, accounting for $1,202,228, or
61%, of total payments.
A Solution
Obstetrician-gynecologists,
including gynecologic oncologists, should be aware of their publicly
reported payments from industry and ensure reports' accuracy.
Professional organizations, including the Society of Gynecologic
Oncology (SGO), should strongly consider proactively developing
guidelines regarding interactions with industry for their general
memberships.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.